Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CHASE RETROGRADE CARDIOPLEGIA CANNULA

K-Number: K964393 · 1997-04-23

ApplicantChase Medical, Inc.
Decision Date1997-04-23
Product CodeDWF
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CHASE RETROGRADE CARDIOPLEGIA CANNULA is the device name listed in this FDA 510(k) record. The listed applicant is Chase Medical, Inc.. It received FDA 510(k) clearance on 1997-04-23 under 510(k) number K964393. The device is classified under product code DWF. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CHASE RETROGRADE CARDIOPLEGIA CANNULA?

CHASE RETROGRADE CARDIOPLEGIA CANNULA is a medical device that received FDA 510(k) clearance on 1997-04-23. The listed applicant is Chase Medical, Inc.. The 510(k) number is K964393.

When did CHASE RETROGRADE CARDIOPLEGIA CANNULA receive FDA 510(k) clearance?

CHASE RETROGRADE CARDIOPLEGIA CANNULA received FDA 510(k) clearance on 1997-04-23, under 510(k) number K964393.

Who is the listed applicant for CHASE RETROGRADE CARDIOPLEGIA CANNULA?

The FDA 510(k) record lists Chase Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CHASE RETROGRADE CARDIOPLEGIA CANNULA?

The FDA product code for CHASE RETROGRADE CARDIOPLEGIA CANNULA is DWF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Chase Medical, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K032531CHASE CARDIAC ANALYSIS SYSTEMK022093CHASE CARDIOVASCULAR PATCH KITK021129CHARE CARIOVASCULAR PATCHK020233CHASE CARDIOVASCULAR PATCH KITK020132CHASE CARDIOVASCULAR PATCH KITK012248CHASE CARDIOVASCULAR PATCH

View all 27 devices →

Related Devices (Code: DWF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260195Elongated One-Piece Arterial (EOPA) 3D™ Arterial CannulaeMedtronic, Inc.K250937Venous Return CannulaeLivaNova USA, Inc.K260043Smart Reactors Camouflage Coated Extracorporeal Cardiopulmonary Tubing Set (SR180C)Smart ReactorsK253203Retrograde Coronary Sinus Perfusion CannulaeMedtronic, Inc.K253671Dual Stage Venous CannulaeSorin Group Italia S.R.L.K253998Clearview Intracoronary ShuntsMedtronic, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑